Cost-effectiveness of portable-automated ABR for universal neonatal hearing screening in India.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 01 01 2024
accepted: 29 07 2024
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: epublish

Résumé

The World Health Organization considers Universal Neonatal Hearing Screening (UNHS) essential to global public health. Rashtriya Bal Swasthya Karyakram has included newborn hearing screening in India since 2013. The program faces human, infrastructure, and equipment shortages. First-line hearing screening with improved diagnostic accuracy is needed. The Portable Automated Auditory Brainstem Responses (P-AABR) can be used in remote areas for UNHS due to its low infrastructure needs and diagnostic accuracy. This study evaluated the cost-effectiveness of P-AABR in UNHS. We employed an analytical model based on decision trees to assess the cost-effectiveness of Otoacoustic Emission (OAE) and P-AABR. The total cost to the health system for P-AABR, regardless of true positive cases, is INR 10,535,915, while OAE costs INR 7,256,198. P-AABR detects 262 cases, whereas OAE detects 26 cases. Portable Automated ABR costs INR 97 per case detection, while OAE costs INR 67. The final ICER was 97407.69. The P-AABR device is cost-effective, safe and feasible for UNHS Rashtriya Bal Swasthya Karyakram (RBSK) programs. Beyond reducing false referrals and parent indirect costs, it detects more hearing-impaired infants. Even in shortages of skilled workers, existing staff can be trained. Thus, this study suggests integrating this device into community and primary health centers to expand UNHS coverage.

Identifiants

pubmed: 39188791
doi: 10.3389/fpubh.2024.1364226
pmc: PMC11345169
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1364226

Informations de copyright

Copyright © 2024 Sahoo, Dwivedi, Athe, Chauhan, Jain, Sahoo, Bhattacharya, Rajsekhar and Pati.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Krushna Chandra Sahoo (KC)

Health Technology Assessment in India (HTAIn), Regional Resource Hub, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.

Rinshu Dwivedi (R)

Health Technology Assessment in India (HTAIn), Regional Resource Hub, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.

Ramesh Athe (R)

Health Technology Assessment in India (HTAIn), Regional Resource Hub, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.

Akshay Chauhan (A)

Department of Health Research, Ministry of Health & Family Welfare, Health Technology Assessment in India (HTAIn), New Delhi, India.

Shalu Jain (S)

Department of Health Research, Ministry of Health & Family Welfare, Health Technology Assessment in India (HTAIn), New Delhi, India.

Rakesh Kumar Sahoo (RK)

Health Technology Assessment in India (HTAIn), Regional Resource Hub, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.

Debdutta Bhattacharya (D)

Health Technology Assessment in India (HTAIn), Regional Resource Hub, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.

Kavitha Rajsekhar (K)

Department of Health Research, Ministry of Health & Family Welfare, Health Technology Assessment in India (HTAIn), New Delhi, India.

Sanghamitra Pati (S)

Health Technology Assessment in India (HTAIn), Regional Resource Hub, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH